302 related articles for article (PubMed ID: 30145509)
1. A review of the neurobiological underpinning of comorbid substance use and mood disorders.
Gómez-Coronado N; Sethi R; Bortolasci CC; Arancini L; Berk M; Dodd S
J Affect Disord; 2018 Dec; 241():388-401. PubMed ID: 30145509
[TBL] [Abstract][Full Text] [Related]
2. [Effect of comorbid substance use on neuropsychological performance in subjects with psychotic or mood disorders].
Liraud F; Verdoux H
Encephale; 2002; 28(2):160-8. PubMed ID: 11972143
[TBL] [Abstract][Full Text] [Related]
3. [Post-traumatic stress disorder and substance use disorder: epidemiology, nature and neurobiology].
Martínez-Raga J; Didia-Attas J; Ruiz M; Knecht CC; Cepeda S; San Molina L; Pérez-Gálvez B
Vertex; 2005; 16(63):325-31. PubMed ID: 16220147
[TBL] [Abstract][Full Text] [Related]
4. Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence.
Balhara YP; Kuppili PP; Gupta R
J Addict Nurs; 2017; 28(1):11-26. PubMed ID: 28252507
[TBL] [Abstract][Full Text] [Related]
5. Neurobiology of Comorbid Substance Use Disorders and Psychiatric Disorders: Current State of Evidence.
Singh Balhara YP; Patnaik Kuppili P; Gupta R
J Addict Nurs; 2017; 28(1):E1-E2. PubMed ID: 28252513
[TBL] [Abstract][Full Text] [Related]
6. Understanding comorbidity between substance use, anxiety and affective disorders: broadening the research base.
Hall W; Degenhardt L; Teesson M
Addict Behav; 2009; 34(6-7):526-30. PubMed ID: 19386422
[TBL] [Abstract][Full Text] [Related]
7. Co-occurring mental and substance use disorders: the neurobiological effects of chronic stress.
Brady KT; Sinha R
Am J Psychiatry; 2005 Aug; 162(8):1483-93. PubMed ID: 16055769
[TBL] [Abstract][Full Text] [Related]
8. Critical exploration of co-occurring Attention-Deficit/Hyperactivity Disorder, mood disorder and Substance Use Disorder.
Regnart J; Truter I; Meyer A
Expert Rev Pharmacoecon Outcomes Res; 2017 Jun; 17(3):275-282. PubMed ID: 28686107
[TBL] [Abstract][Full Text] [Related]
9. Temporal sequencing of lifetime mood disorders in relation to comorbid anxiety and substance use disorders--findings from the Netherlands Mental Health Survey and Incidence Study.
de Graaf R; Bijl RV; Spijker J; Beekman AT; Vollebergh WA
Soc Psychiatry Psychiatr Epidemiol; 2003 Jan; 38(1):1-11. PubMed ID: 12563553
[TBL] [Abstract][Full Text] [Related]
10. Pathways to comorbidity: the transition of pure mood, anxiety and substance use disorders into comorbid conditions in a longitudinal population-based study.
de Graaf R; Bijl RV; Ten Have M; Beekman AT; Vollebergh WA
J Affect Disord; 2004 Nov; 82(3):461-7. PubMed ID: 15555699
[TBL] [Abstract][Full Text] [Related]
11. Psychiatric comorbidity in forensic psychiatry.
Palijan TZ; Muzinić L; Radeljak S
Psychiatr Danub; 2009 Sep; 21(3):429-36. PubMed ID: 19794370
[TBL] [Abstract][Full Text] [Related]
12. Pharmacotherapy of comorbid mood, anxiety, and substance use disorders.
Brady KT; Verduin ML
Subst Use Misuse; 2005; 40(13-14):2021-41, 2043-8. PubMed ID: 16282091
[TBL] [Abstract][Full Text] [Related]
13. Substance use disorders comorbid with mood and anxiety disorders in the Australian general population.
Prior K; Mills K; Ross J; Teesson M
Drug Alcohol Rev; 2017 May; 36(3):317-324. PubMed ID: 27324816
[TBL] [Abstract][Full Text] [Related]
14. Effects of anxiety and mood disorders on craving and substance use among patients with substance use disorder: An ecological momentary assessment study.
Fatseas M; Serre F; Swendsen J; Auriacombe M
Drug Alcohol Depend; 2018 Jun; 187():242-248. PubMed ID: 29684892
[TBL] [Abstract][Full Text] [Related]
15. [Co-occuring mood and substance use disorders].
Adida M; Kaladjian A; Fakra E; Belzeaux R; Azorin JM
Encephale; 2014 Dec; 40 Suppl 3():S8-S13. PubMed ID: 25550243
[TBL] [Abstract][Full Text] [Related]
16. Self-medication of mood disorders with alcohol and drugs in the National Epidemiologic Survey on Alcohol and Related Conditions.
Bolton JM; Robinson J; Sareen J
J Affect Disord; 2009 Jun; 115(3):367-75. PubMed ID: 19004504
[TBL] [Abstract][Full Text] [Related]
17. Antidepressant-induced mania with concomitant mood stabilizer in patients with comorbid substance abuse and bipolar disorder.
Lieberman DZ; Kolodner G; Massey SH; Williams KP
J Addict Dis; 2009 Oct; 28(4):348-55. PubMed ID: 20155604
[TBL] [Abstract][Full Text] [Related]
18. Secular trends in first hospitalizations for major mood disorders with comorbid substance use.
Minnai GP; Tondo L; Salis P; Ghiani C; Manfredi A; Paluello MM; Baethge C; Baldessarini RJ
Int J Neuropsychopharmacol; 2006 Jun; 9(3):319-26. PubMed ID: 16316480
[TBL] [Abstract][Full Text] [Related]
19. Patterns of affective comorbidity in a clinical population of dually diagnosed adolescent substance abusers.
Bukstein OG; Glancy LJ; Kaminer Y
J Am Acad Child Adolesc Psychiatry; 1992 Nov; 31(6):1041-5. PubMed ID: 1429402
[TBL] [Abstract][Full Text] [Related]
20. Substance use disorders in patients with posttraumatic stress disorder: a review of the literature.
Jacobsen LK; Southwick SM; Kosten TR
Am J Psychiatry; 2001 Aug; 158(8):1184-90. PubMed ID: 11481147
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
